News Agency
Men's Weekly

Bio4t2 announces trial evaluating repeat infusions of CAR-T targeting solid tumors without lymphodepletion

  • Written by PR Newswire
Bio4t2 announces trial evaluating repeat infusions of CAR-T targeting solid tumors without lymphodepletion

SAN DIEGO and SHANGHAI, Oct. 17, 2023 /PRNewswire/ -- Bio4t2® received regulatory approvals to repeatedly administer patients with T cells engineered to express a chimeric antigen receptor (CAR) targeting BT-001, an antigen on solid tumors identified using the PrismCore platform. The CAR-T, termed B4t2-001, are predicted to engraft...

Read more: Bio4t2 announces trial evaluating repeat infusions of CAR-T targeting solid tumors without...

How Family Lawyers Can Help Reduce Conflict During Separation

Separation is rarely straightforward, and the emotional weight it carries can make even practical decisions feel overwhelming. When communication between separating parties breaks down, disputes over property, finances and parenting arrangements can escalate quickly and become far more damaging than... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion